XML 49 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Share based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Fair Value of Options
The fair value of the stock options granted was estimated on the date of grant using a Black-Scholes option pricing model with the following weighted-average assumptions:
Years Ended December 31,
202220212020
Expected stock price volatility62.1 %65.4 %75.1 %
Risk free interest rate1.7 %0.6 %1.6 %
Expected life of options (years) 5.345.405.67
Expected annual dividend per share$— $— $— 
Schedule of Stock Options Activity
A summary of the Company's stock options for the year ended December 31, 2022 were as follows:
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Years
Aggregate
Intrinsic
Value
(in thousands)(in millions)
Options outstanding, December 31, 201916,724 $9.15 
Granted4,362 $9.98 
Exercised(5,243)$8.11 
Forfeited(1,376)$10.42 
Expired(435)$13.33 
Options outstanding, December 31, 202014,032 $9.54 
Granted3,262 $16.53 
Exercised(1,483)$7.05 
Forfeited(844)$12.97 
Expired(236)$13.28 
Options outstanding, December 31, 202114,731 $11.08 
Granted5,733 $11.53 
Exercised(660)$6.58 
Forfeited(495)$12.57 
Expired(245)$12.84 
Options outstanding, December 31, 202219,064 $11.31 6.6$36.7 
Vested and unvested expected to vest, December 31, 202217,492 $11.22 6.4$35.1 
Exercisable at December 31, 202210,938 $10.59 5.0$29.0 
Schedule of Non-Vested RSU Activity under the Plan A summary of non-vested RSU activity under the Plan for the year ended December 31, 2022 is as follows:
 
Number of
Shares
Weighted
Average Grant
Date Fair
Value
Weighted
Average
Remaining
Years
Aggregate
Intrinsic
Value
 
(in thousands)
(in millions)
Non-vested units as of December 31, 20195,792 $11.18 
Granted4,692 $11.29 
Vested(2,164)$10.70 
Forfeited(1,240)$11.14 
Non-vested units as of December 31, 20207,080 $11.35 
Granted3,191 $16.94 
Vested(1,863)$15.77 
Forfeited(1,067)$12.82 
Non-vested units as of December 31, 20217,341 $13.90 
Granted5,048 $11.93 
Vested(2,251)$12.48 
Forfeited(421)$12.06 
Non-vested units as of December 31, 20229,717 $13.07 2.1$118.6 
Schedule of Equity Compensation Expenses
The following table summarizes information related to compensation expense recognized in the Consolidated Statements of Operations related to the equity awards:
Years Ended December 31,
(in thousands)202220212020
Research and development expense$25,089 $17,340 $20,817 
Selling, general, and administrative expense51,423 40,498 28,334 
Total equity compensation expense$76,512 $57,838 $49,151